Latest / Digital Leaders Club By Ingeno / Brett Kleger, CEO at Inspire | Healthcare Technology, AI & Patient Engagement
Transcript
- riverside guillaume raw video cfr ingeno's studio 0080: Welcome to Digital Leaders Club. I'm Guillaume Dicheno, founder and CEO at Ingeno. This show is built for the leaders shipping real products into hard markets. And today that means someone building technology for one of the most complex industry there is. I'm joined by Brett Pleager, Chief Executing Officer at Inspire. Welcome to the show. Ingeno: Thank you, Gum. I I really appreciate the opportunity to speak to the folks. riverside guillaume raw video cfr ingeno's studio 0080: All right. So Brett, before we get into the company a and what you guys do, how do you end up in, you know, building healthcare technology software? Because you know, healthcare is a is a it's typically a path that you you not don't necessarily, you know, draw in front of you, it kinda happens to you, right? It's sometimes a sinuous path to get there. Ingeno: Yeah, a and my my path is very unique and I'll share just a a brief description of it. I'm actually a a lawyer by training. I call myself a recovering lawyer at times, so I spent all the nine years, riverside guillaume raw video cfr ingeno's studio 0080: Okay. Ingeno: most most of the nineties I was practicing law. and a lot of the law I practiced was helping healthcare, helping medical providers with various cases. And I really enjoyed the industry, but I also really enjoyed helping improve healthcare. And I found the opportunity a little over twenty-five years ago to join a startup back in the dot-com eras in healthcare. and I've been there ever since and I I I love the idea of using technology to improve patients' lives, to save lives, work with the pharmaceutical industry as well and I've navigated through the last I guess twenty seven years in this industry in various roles but always in a focus of how do we create how do we use technology to improve experiences of patients, of caregivers and of physicians. riverside guillaume raw video cfr ingeno's studio 0080: Nice. So yeah, t tell us about Inspire exactly. What do you guys do actually and and what's the product? who is it for? and and what is it used for? the scale, right? I don't want I wanna know everything. Ingeno: Absolutely. So Inspire and it's a at inspire dot com, very easy to find it or or or the app store. Inspire is essentially like a Reddit or Facebook for healthcare communities. I I sometimes explain it and said if Reddit and WebMD had a love child, that would be Inspire. it was founded over 20 years ago with the premise of let me create online communities where patients can talk to one another. So if I'm a patient and I have prostate cancer, I want to talk to other prostate cancer patients to understand their experiences, what's going well, what's not going well, and just have that community. And that's really what Inspire was founded upon. So over the years, it's gone from a few to nearly 300 different communities now of patients with diseases. that essentially talk to each other. In recent years w why I said the WebMD is we've sort of added a lot more content, a lot more engagement. So now patients don't just come to inspire to talk to others, but they also learn about other opportunities, they learn about treatment opportunities, they learn about what the pharmaceutical industry is doing and the next wave of solutions that can help them. So they learn a l a lot of things and then we use it to help connect them to the medical manufacturers to help give insights about what the next wave should look like. riverside guillaume raw video cfr ingeno's studio 0080: Hm. So it's it's patients, but it's also the professionals as well, right? Ingeno: Correct it. So it's it's mostly i it is patient and caregiver facing is the primary focus of it. But professionals will use it to come on to give some insights, or to connect with the patients. riverside guillaume raw video cfr ingeno's studio 0080: Okay, so explain to our listeners what's your what's your business model. So as a patient, do I need to pay to be in in your in your application or how do you get your revenue from and yeah, who are let's say the the typical personas or the the the user types that that gravitate around your system? Ingeno: Absolutely. So from a patient perspective it is completely free. and actually patients can navigate without even signing up on the platform to read everything. If a patient wants to post, it's similar to a a Reddit or a Yelp or something that someone can read reviews, but if you want to give a review you sign up for a an account. So for patients it is free. They can sign up and it's free, a patient caregiver or anyone. the revenue model has has expanded over the years. for the first twenty plus years the primary revenue model was digital advertising. So our primary audience was ad agencies that were typically putting up advertisements for products. So they're putting up pharmaceutical products. If you go onto the psoriasis community, an advertiser for a psoriasis product would riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: pay us for the impressions. And that was that was the business model. I was brought in as CEO several years ago to help expand that and really look at how do we not just create different revenue models but also create other opportunities for our patients. So the expansion has been primarily in pharmaceutical industry, so staying the industry is that that they're the primary drivers where we're essentially connecting patients to the pharmaceutical industry. So the pay the the the industry will pay us to help find patients. Whether riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: it is we want to find patients we could just talk to to learn more about their experience on our products or we want to find patients we could talk to to understand what the unmet needs or burdens were. so that they could determine how to build a portfolio. or sometimes we wanna find patients because we're running clinical trials and we need more patients for those trials. So for the most part, that's been the premises. How do we bring how do we c we're a we're a connector, almost a recruiter of patients for the pharmaceutical riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: indust industry. At times it expands into other healthcare entities, but the pharmaceutical industry is is by far the most significant provider that that's searching for the connection to the patients. riverside guillaume raw video cfr ingeno's studio 0080: Very interesting. nice kind of yeah, network here. so tell me, Brett, you as a CEO, what's what's a typical day or week look like? How do you spend your time? Ingeno: That is a great question. because it's i i i i riverside guillaume raw video cfr ingeno's studio 0080: Ha ha ha. Ingeno: i typical i i is rarely the the the norm there. so a number of d different areas. I I I'm I'm a CEO who I follow management style to hire really bright people and let them do their job. So for the most part I say that the the team that I have, I'm there to support them, give them guidance. I will Typical week I will spend a good portion of my time trying to support our sales and and service teams with the clients. So through network connections, through messaging to help explain the story, to s support the sales and client service. That's probably one of the biggest things that I do. certainly as a CEO I serve a board and investors so I have more than a significant amount of connection with the investors. Our investors are are are very involved with the business, very strategic. because they came in a company that was over twenty years old and they needed a change of direction, I've had a lot more involvement with investor base that I've had in prior companies in these roles just because they're trying to look they're looking for a change. and then certainly from a technology, we are a technology company through and through. And I have an incredible technology team and I try to spend time with them not just to understand what they're pulling together but to push the team to utilize new technologies, to think out of the box, to be more aggressive than just following the same model that everyone's been doing for for a number of years. And that includes things like like AI and NLP and and other solutions. riverside guillaume raw video cfr ingeno's studio 0080: Nice, yes. And and we'll come we'll come back to that. But before Ingeno: Yeah. riverside guillaume raw video cfr ingeno's studio 0080: tell me Rhett, what's the the part of the the product or company that you're the most proud of right now? Ingeno: most proud of the patient engagement. when I joined the company, it was what you'd expect from a a twenty-year-old company that had I wouldn't say gotten stale over time, but but hadn't necessarily used all the most modern technologies. And what that meant is we had a patient we had patients on the system That may have seen the same functionality for year after year and didn't have a lot of enough innovation in my mind. riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: if I think about the key metrics, I always think about how engage our patients. So when we email them or text them or message them, are they responding? what are the conversations they're having with other patients? are they making an impact? And So what I've seen over time is significant. we s we like to call our patients sometimes ultra engaged. patients that come to inspire are individuals that generally are altruistic. They want to help others. They're there riverside guillaume raw video cfr ingeno's studio 0080: Mm. Ingeno: not just to learn about themselves, but to to share their stories and help other people. it's been incredible watching and listening to those stories. of how they're helping other people. from a metrics perspective, I will track things like email open rates and response rates and how much are engaged and seeing how engaged they are. But then every month we will do an internal town hall and I would say one of the most impactful and influential parts of that of that meeting every month is we dedicate time to have our community team, which supports the patients, share some stories. And every month it is it's often a teard you know, a a a a teardropper in terms of the stories they have. But more often than not, it is just hearing patients talk about the impacts they have on other patients is an incredible story. And in my career, I spoke twenty odd years ago, or maybe fifteen years ago at a at a conference about the idea of try law and leave it like I did. But the premise was I wanted to find something in my career that I was helping other people and listening to that is just very inspirational. So you're having a bad day, just hearing the story of how we connected two people or a group of twenty people and the impact they've had on each other, that really helps you get through the the tough days. riverside guillaume raw video cfr ingeno's studio 0080: Mm. I love it. I love it. Yeah, it's it sounds like some of your patients or users are finding even meaning using your platform, right? that's that's that's awesome. That's awesome. what would be, let's say, the hardest part of building a product like yours for healthcare, for health the the healthcare industry, that someone outside that industry probably wouldn't really fully appreciate that. Ingeno: if you asked me that question several years ago, I might say that the hardest part is the healthcare and pharmaceutical regulations and challenges associated with that. That's that you always need to navigate and make sure you're having proper processes, you're not giving out poor information. that is how I probably would have generically responded for most of my career. I think the last couple of years has been a new dynamic which is incredible in our lives but also difficult. And that's the you know, through the AI and ChatGPT and Gemini, which I think has incredible value and I'm sure we'll talk more about that. But the challenge that it's provided is making sure that you're giving the right information to patients. So we Whether it's this company or prior companies, we're always looking to make sure that we have the right regulations and checkpoints in that healthcare advice or information connections are accurate. And because people can generate information via the various AI models, occurly we have to look at that and say, make need to make sure that you're getting the right information. No different than you and I going to our doctor and saying We just read this online and this must be true, there's always going to be information out there that that you have to validate. So I think the overcoming that validation is difficult. And then as a digital platform, unlike it unli or or similar to all digital platforms, we'll have the challenge that people are often getting their answers right away from a chat GPT or something like that, and then they're not coming to these platforms to learn more. So that that's gonna be a challenge for SEO and traffic and getting the right information that I think we'll w we all decide to live with as a new norm. riverside guillaume raw video cfr ingeno's studio 0080: Are you seeing more and more people kind of getting let's say a a an opinion from an AI for their health condition? So instead of going Ingeno: Absolutely. riverside guillaume raw video cfr ingeno's studio 0080: to the doctor first, they go to ChatGPT first or Claude. Ingeno: Absolutely, and and to be honest, it's probably what we do and I think my kids do that and I I I I think that's the the reality. riverside guillaume raw video cfr ingeno's studio 0080: Yeah. Ingeno: But we're seeing some of that on the platform where we're seeing conversations. The conversations have changed over the years. So conversations used to be a lot about this the experience I've had, my doctor told me this, why don't you try this? To this is now what I found on the internet. And and so people are sharing that amongst others on the internet, which is incredible when there's accurate information and tiny information, but can be disruptive if you don't have some type of validation or expertise to say that is the right information that you should follow. riverside guillaume raw video cfr ingeno's studio 0080: And what's your what kind of let's say responsibility you feel your your system has to make sure that you know people are not sharing stuff that isn't verifiable or that it's just what an AI said or what another forum said. so because I From what you're saying, I feel it's more like an open discussion, right? So so validating everything is kinda hard to do. Ingeno: Correct. Yeah, so so we we've debated that significantly. so I think from a responsibility perspective, our responsibility is providing an open forum for people to have discussions. and make sure that discussions are appropriate. So we take a lot of effort, for example, to make sure in our discussion groups there's not inappropriate com there's not improper comment, disrespectful comments, there's not people trying to sell things to them in those groups. That's actual discussion forum to make a a h a healthy discussion. we also will bring in experts, so we'll have sessions call them ask the experts where we'll we'll say for this period of time, an actual verified medical, an MD, a medical doctor, a a a DO, some kind of medical expert will come in to answer questions for people. but we also don't want to limit discussions that people are having because often the discussions and and discussions for the most part are around personal experiences. So if someone says, riverside guillaume raw video cfr ingeno's studio 0080: Supporting each other, I guess, yeah. Ingeno: This is what happened to me, we wanna we wanna make sure it goes on. So we'll make sure it's not inappropriate, we'll make sure there's not chat bots, that there are actual real people having discussions. riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: And we have a 247 team that monitors discussions to make sure that discussions do not become inappropriate in any way or improper or making people feel uncomfortable. So people feel that it's a safe space they can have discussion, but we're we're not going to redirect the discussion unless we feel that the content is becoming i you know inappropriate or something that is just too far too far left field that's going to offend some of the people in the discussion. riverside guillaume raw video cfr ingeno's studio 0080: jumping into AI So nowadays every company has to become an AI company, right? So there's an AI let's say strategy that the board asks for, the CEOs asked for, and kinda trickle down s to to everyone in the company, right. So in in the case of Inspire, what's what's your play here? What's how do you how do you feel leveraging AI? will be let's say a differentiator for you or an accelerator for you. Ingeno: Yeah, good question. And we we use AI significantly riverside guillaume raw video cfr ingeno's studio 0080: Yeah. Ingeno: and a and you're right, there's a a board discussion is generally falls into two categories on AI. One is how do you reduce cost using AI? That's a very common d discussion riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Yeah. Ingeno: request. And the second is We know that if we say that we're AI, we're gonna drive the value up, so how do we just put AI all over the place and you know, you see you riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: see companies putting AI in their name and a and certainly it's riverside guillaume raw video cfr ingeno's studio 0080: Yeah, yeah. Ingeno: one of those things that from a value perspective. I look at AI much more pragmatically, and and so the challenge that that my leadership team and I have gone through in AI is is understand Let's make sure that we're not just checking the box and saying we're using AI, but let's actually figure out how to use AI in the best manner. So riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: there's certain things that just gives us greater capacity and productivity. There's basic things that we're doing. So in our code development our developers will use AI to generate code. There our QA teams will use AI to generate test cases. there's obviously a manual review of that and input so there's not you know there's people behind that. But it's given us I our our CTO has told me as they evaluated we've had a fifty two percent increase in productivity based on AI just from w being able to produce more code, produce test cases much more quickly without AI. we also generate content. So we're a significant content generation company in terms of information about the industry, and we utilize AI again to generate content with the proper QCs so you're not shown with hallucinations. So those are what I would say those what I would call productivity uses of AI and we're continuing to do that. our sales reporting, I I I use it last night I needed to get some new reporting out and by writing a few prompts in AI, my reports came out in minutes that would probably would have taken hours of an individual doing that. So there's there's all those productivity things, which I think are are necessity in the way that the industry's moving. but I think there's there's two other areas of AI I want to sort of highlight where I think is the the true growth. so one is we have found ways to use AI to generate what we call AI insights. So these are conversations that patients are having. So if you think of the conversations we have Billions of words of conversations. I think that the last time my marketing ran the metrics, the average conversation on our site is 16 times the length of a Facebook conversation, for example. So you're having paragraphs with information, people sharing one another about specific disease states. And we use AI to generate insights about what's happening. So we could tell our customers, based on the conversations, These are unmet needs, these are what people are seeing. We can we can very riverside guillaume raw video cfr ingeno's studio 0080: Mm. Ingeno: quickly understand what t what people are talking about, what the key topics are. So that to me is an incredible use of of AI and something that even if we had people scouring through that on a daily basis, they may not pick out those triggers. So AI has been very successful and we continue to refine algorithms to learn more about them. the second is a little more philosophical, but it's something I and I know I've been through some seminars hearing this from other CEOs and and the idea is can you create a technology an AI driven technology team and almost remove technologists with which I think it's a it's a concept and not necessarily some reality and it scares me having a a A son who works as a computer scientist, that always scares me of his future too. riverside guillaume raw video cfr ingeno's studio 0080: Yeah. Ingeno: but really what what we've been looking at is I'll call a skunk team. So we'll take a few pe a few people, a few technologists and say, we want you to go around the company and learn all the processes going on in the company. And come back and understand which of those can be enhanced or improved or made more efficient using AI, then test those things, and then you know improve productivity. So doing that in a way that's structured versus just saying we're gonna remove jobs or we're gonna be more productive. I always look at it too as a CEO. Of course, every CEO and anyone listening, we're always under pressure to keep costs down. And and that's gonna be the the headlines that people think about with AI, I look at it differently and say, I want to keep being more productive to generate more revenues. How can I use AI to be more productive to then generate more? So I'm not using it to say, let me remove a few jobs, but rather let me do more with the same. riverside guillaume raw video cfr ingeno's studio 0080: Yeah, that that makes sense. And so if I summarize what you just said, first one is productivity. So use AI to boost your own or your individual productivity on existing tasks, right? As you as you mentioned, let's say I wanna do a report instead of creating a new one by hand and take me takes me hours, it takes a few seconds to to give the prompt. While the AI is thinking about it, I can do something else and then it comes back a few minutes later with a nice colorful you know report. Then and that also includes software engineering, right? in in productivity. And then create new value opportunities. That th those create value new value opportunities, right? as you said, the insight that that the feature that you mentioned about providing insight from conversation. to let's say the ones that are let's say the the pharmaceutical companies. then the third one is kind of related to the first one, I guess, right? But instead of improving your productivity on existing tasks, what I think you're saying is that reinventing the processes, reinventing the workflows so that there's less tasks to do. And then those that humans do are really the ones that where humans truly bring value. So all that's repetitive, try to give that to the human to the machine. And then what needs creativity and judgment, only a human can can do, then it's a human. did I did I get that right? Ingeno: Th very yeah, very accurate. riverside guillaume raw video cfr ingeno's studio 0080: Alright, so for let's see creating value. so I guess that's the one that probably drives the other ones because I think increasing productivity and let's say this is my editorial now. Ingeno: Yeah. riverside guillaume raw video cfr ingeno's studio 0080: Increasing productivity is something everyone is currently doing and everyone is just by experimenting is kind of you know grasping, right? So some will be faster at grasping it, some will be slower, but eventually. most people will will get to that. But being able to see opportunities like the insight that you mentioned, I think that's kind of the key in most industries. so I I'm I'm really glad you mentioned that. Do you see any other kind of AI capabilities like that that you see could really benefit your organization by providing better value and and how those opportunities or capabilities would help either the users or let's say your clients, the pharma and and such. Ingeno: Yeah, absolutely. So so I I would say and I'll I'll stick on the sales and marketing side for a moment because we've had some unique values that I hadn't even thought about as that team is testing at AI. when we're selling, we have a typical sales deck and everyone has their marketing decks and PR and one pagers and what have you. But what we found our team doing is saying, first let's use AI to understand the unique needs of our customer base riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: and then using AI to create bespoke materials for those customers in sessions. So instead of saying let's create a master demo and master slide deck and master materials for everyone and use that, we can create a template of sort But then we'll use AI before we meet with someone and say, what does this company, what are the unique challenges of this company, and and company and individual riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: and then essentially say to AI, okay, create a sales presentation or create materials that addresses these issues to this audience. And what's come out are th are things that It's a productivity improv improvement as opposed to trying to d do that. But also I think what we found is more insights coming out as we look at things that we wouldn't have otherwise otherwise noticed. I've had riverside guillaume raw video cfr ingeno's studio 0080: Yeah. Even have the time to analyze, right? Because there's a lot of unstructured information that a human would need to kind of digest before they they could come up with the same kind of pre customized content. Ingeno: Correct, yeah. So so there's obviously a productivity piece. If I have a if I have a meeting with a brand new client tomorrow morning and I don't know much about them and I didn't have a lot of discovery, certainly it's productivity I could say use AI to generate something unique for them. But I think more important to me is I could we use AI to learn something about them and produce a message that might resonate to that audience. that I wouldn't otherwise have thought about. riverside guillaume raw video cfr ingeno's studio 0080: So so you mentioned the insight aspect. Then you you mentioned let's say having customized let's call those pitch decks or to interest your your your potential customers. so is it something that's already in place, something that's kind of in motion, more like in a lab kind of form, or no, we are our sales team are fully autonomous now and and they they they do this and now they they close let's say three times more in less time. Well what's the current situation, let's say. Ingeno: I I'll just in between those. So two to three months ago, my growth officer shared some ideas of what she was trying with customers. So we've been trying them recently, it's been resing really well. but I wouldn't say I wouldn't say that approach is something that we've put into full production yet, or have metrics to show the success of that. anecdotally, it's been incredible. I've been part of some of those meetings and seeing the reception to that makes a user feel great that you thought about them and you have riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: something more s specific to them. And then internally I see that yes we've done that and instead of that taking four days of preparation that was twenty minutes of riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: of doing that. That's been incredible. But I wouldn't say that I have great metrics or can showcase the the ROI of doing that. riverside guillaume raw video cfr ingeno's studio 0080: You it's still kind of at the early beginning of like rolling this out, right? Yeah. Ingeno: Correct. Yeah, versus the the the insight generation, that solution, that's been very successful. we we rolled that out about a year ago. It's been incredibly successful in generating solutions that and insights that we weren't be able to generate previously, or if we were, it would have taken us a number of data scientists a riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: few months to to figure that out. Might be too late versus the the the message. riverside guillaume raw video cfr ingeno's studio 0080: Yes. and what kind of form does it take, let's say, for your your customer they they kind of have a a feed of of insight. Can you explain a bit the user experience they they live? Ingeno: Correct. Yeah, so so typically what we're delivering them in the insights is a a PowerPoint of a PDF presentation, a d a document that is on a weekly or monthly basis. Here's a four to ten page document, depending on the types of insights, to almost be a storyboard of here's what we're hearing in the marketplace. So sometimes the insights are generated and There's a storyboard of a n of series of graphs. Sometimes it is just combining the anecdotal messaging, depending on what they're looking for. Some 'cause riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: some customers, if you're a pharmaceutical company, for example, and you have a product in market, you want to understand the feedback of those users to understand things like the mode of d of distribution, side effects, benefits they're getting, any Often you hear conversations around economics, so people put together different economics around that. but if you're portfolio manager or in the R and D of pharmaceuticals, what you're really trying to understand is what are those unmet needs that we have to think about. How how do we think about there's a million migraine products out there, but obviously we don't have the perfect product, migraine still exists, you know, for for for any any any condition that still exists, the products clearly aren't perfect. So what they're trying to understand is, okay, what are those unmet needs? How can we improve the symptomology to make sure that we have a a better experience and and can produce a better product. riverside guillaume raw video cfr ingeno's studio 0080: Right, where where they should kind of focus, right? What's the what's the most discussed? tell me about how compliance, privacy, security, is kind of defining how how you do how you build your your product. How much is it of a friction and how do you kind of let's say mitigate that? Yeah, in healthcare in general it's super It's a super sensitive, let's say, aspect. Ingeno: Yeah. Yeah. so I would say in building things out it hasn't necessarily been a friction, as more of just an understanding i it's when you're in this space, you understand the guardrails. riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: you understand the guardrails of how do you wanna store data, how you collect data, you have HIPAA, you have how do you handle PHI? You've got GDPR and you're dealing with European data. you have gazillion patient privacy that are both federal, international, and state driven. So riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: I would say that everyone that we bring in the organization understands some of those. We have outside support to understand the changes in those. And you're just building product around those concepts to make sure that you're compliant. There's a lot, a lot of non-compliant companies out there and solutions and and and not because they do it on purpose, they just may not understand it or have the experience. So for us and and and one being the s a company of our size and and company of our our nature and then also Me personally it's a a big remit of mine, make sure that we're compliant. So for example, we went through SOC two certification last year or earlier this year, I think we we finished it, which is just a certification to make sure that all of our processes are buttoned up and and we're following those. so I I would say from a product perspective it's not a friction. those are frictions often with end users, with w and more with c at the customer base, depending on the customer. even though there's various regulations that are widely distributed out there, every customer does not interpret them the same. So inevitably you're gonna find a compliance officer, a lawyer, regulatory person in one of our customers who has a different interpretation. a and thinks they might have more control over the product and we've run it into some of those. so from our perspective, that's a friction that we just have to look for more flexibility. I'd say early in my career when I'd have them and I'd I might bring in our chief compliance officer or our outside counsel to explain to that person why their interpretation of a regulation is wrong or is is too stringent, you can't win doing that. so instead what you do is figure ways to say, okay, if customer A has someone that believes that we need to put the following privacy language in our system, maybe we have to put that to satisfy their need versus fighting over it. So it's been It it certainly is a friction at times when you're dealing with large companies that might have typically it is a an individual who has a different interpretation or reading of a of a regulation and you just need to say, To work with that company I just have to have the flexibility to address that. riverside guillaume raw video cfr ingeno's studio 0080: Yeah. As long as it doesn't contradict other aspects that you would need to, yeah, change and then not be compliant on those. yeah. Ingeno: Th that that is the game we play, yeah. That's that that is the difficulty. riverside guillaume raw video cfr ingeno's studio 0080: so Brett, looking forward, let's say you could snap your fingers and have a new awesome AI feature in your solution. What would that be? Ingeno: That's a great question. what I would love to have for our patients is the ability for you know, as they are having conversations with one another, I'd love to go back in to use AI to find relevant topics or conversations to meet that need. Meaning riverside guillaume raw video cfr ingeno's studio 0080: Mm. Ingeno: They're having conversations constantly and they can search and old materials, but for the most part, conversations over the last several years are not materially different in terms of what's happening with their disease state. Obviously AI is, but there's not gonna be that significant of change in most cases, with exceptions. You have you know GLP one didn't exist years ago and those are relatively new conversations. But I'd love to have a patient come and open a conversation and say this is asking the audience and hear something, and using AI to help bring together prior conversations and maybe even engage prior individuals to bring those dis those discussions together. I I I think that would be from a user perspective very valuable to not reinvent the wheel or search forever, but really have those have those conversations front and center and have those insights. riverside guillaume raw video cfr ingeno's studio 0080: So like let's say past conversation two users have independently and find out that they have some common interest in in that sense or Ingeno: fine they have common interest but almost so so I would say this over let's say over the last ten years if we're talking about psoriasis and people using certain medications and side effects or or or issues of how they handle the the warm weather for example. Some some some t topic like that. if a user would come in today and say it's It's a summer heat, I'm struggling with this, I'm using this product and a and any suggestions on this. I'd love to be able to not just have other folks answer that and respond in the present, but for us to to to figure out how would AI go back in history and summarize here's the different conversations that have happened over time on this topic. and what happens then is not only do we have members that are talking to each other in the community, but members can create private links to one another. That that's one of the great benefits is members often find that they're having a conversation, a a we'll call it the the Reddit Yelp type conversation that everyone's listening to. And they say, I found someone with a like interest or similar to me. I don't want to I don't want the public seeing my whole conversation. So they create those individual and through the platform they can safely have those conversations with other people. So I'd love to be able to have those connections of common people if they're looking for something that's unique, that's been talked about in in different forums. riverside guillaume raw video cfr ingeno's studio 0080: Right. So and and all of this is for just maybe saying the obvious here, but to improve user engagement, stay on the platform, willing to share more and willing to yeah, participate more, right? Ingeno: Exactly. The more the more that a user can stay on the platform, I I mean, from a business perspective, the more time on the platform, the more people on the platform, that that that's genera it's revenue generation for us. And and I I I don't say that as often with the full team because there's an altruistic piece of this, but at the end of the day we're also saying I'm not gonna be shy, we're in the business to make money. And that drives it. So riverside guillaume raw video cfr ingeno's studio 0080: Yeah, absolutely. You can have values. You can have values, have ethics, but you still need to make money to stay in business, right? Yeah. Ingeno: Yeah. Yeah. So I think that that would be a way to keep the the user engaged. and I think our users would really I think they'd really love that if they could very quickly find the answers. I mean we're we're in an environment today, especially when you think about AI, all of us. We want our answers in seconds. We don't want to be searching for answers. So if we can just bring answers riverside guillaume raw video cfr ingeno's studio 0080: Right. Ingeno: to people the connection quickly, that that would be much better. Absolutely. riverside guillaume raw video cfr ingeno's studio 0080: Yeah, especially when you're struggling, I guess you you want you want a a quick solution. so tell me about let's say the competitive landscape for you. Are there other platforms like yours or are you in competition with let's say other kind of type of organizations that kind of target the same client? Ingeno: Yeah. there's there's a couple just smaller smaller platforms similar that that haven't been around as long, th that that don't focus as much. I would say there's two types of competitors that we're seeing in terms of finding communities. one would be the big generic companies, again, Reddit, a Facebook, people are going on on groups there. To have conversations and obviously going on for a lot more than just healthcare. So there are certainly conversations that you can go into those platforms and navigate into to find someone talking about that that condition. So those are the big players that are again not healthcare specific. then we'll find the patient advocacy groups. So Each condition or many conditions have groups out there. think of the American Cancer Society, the Susan Coleman Foundation, things like that. we have I think it's about a hundred and ten of those organizations now are partners of ours, meaning that they will send their users to us to have those conversations. We're the safe platform for them. But there are some big organizations that people will go to those platforms to have those conversations directly with with one another. So riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: for the most part, they are partners, but there are a few of the ABZ groups that try to have them themselves. I would say on occasion there's a couple of pharmaceutical companies that are trying this. I find that from a personal perspective business I I I I I don't agree with that strategy because I think in general what we found is patients generally don't like pharmaceutical companies. They don't trust there's not a lot of trust and like. Obviously there's many exceptions and and and the products they did are the ones that make our lives better, so there's a great part there. But patients are much more willing to share with one another versus let me go share with big pharma. or an individual big pharma. So a couple of them are trying them. Every few years someone tries something and says, we want to build the big pharma patient experience. And they typically fall off. So I don't think we'll stop it over time, but there are a couple out there that have tried to create their own special and they they they want to put their brand in front of patients. riverside guillaume raw video cfr ingeno's studio 0080: Nice. So y yeah, it sounds like you find found the right angle, right? So you you're you're still kind of exposing user insights to to pharma, but you're mostly creating a community from the user persp perspective. You're creating a community, a way a place to exchange, and and to yeah, to to to bond somehow. Ingeno: Yeah, yeah, you want so so a big thing to the patients is just trust. So we want to make sure that patients trust us, they can trust our platform, they can trust the conversations, and then if they would like to engage with pharma, they have that opportunity. riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: and I think that that's that's a big thing that we'll see. So even when we work with pharmaceutical companies, We will go out to the patients, we won't have their pharma companies go out, we don't share that data there, and we'll go out on behalf of the company and say Here's a partner of ours. They'd like to understand this if you'd like to share. And that's where we'll get people sharing, but only those who have raised their hands said, Yes, I'd like my insight shared with these companies. If they don't want it, riverside guillaume raw video cfr ingeno's studio 0080: Yeah. Ingeno: that's and and we also allow the patients, if they if they want to have the conversations, but they don't want those shared, th they they own their conversations. They own that's private for them. So they have that ability to turn things on and off. riverside guillaume raw video cfr ingeno's studio 0080: Awesome. so let's say what would be a technical recent tech technical technology decision that you guys took that you'd call a real win? Ingeno: I would say the biggest thing we did is to enhance our user profiles using AI. what I mean is patients share X amount of information about themselves and their profile and they'll say, Here's my name, my date of birth, and whatever information they they they want to share. But like many, the same thing that when you and I will sign up for various systems. We may go to the required information, not all the optional information. and we always try to enhance and say, Can you share the the more you share, the more we could tailor content towards you. what we've found the technology is based on our conversations, we can then tailor their experience towards them. So even if someone doesn't say, the way I'm a caregiver and I have these comorbidities and I'm in this community. If their conversations are are leading that way, we might say, Well, let's tailor their their experience. So now when everyone comes to the platform, their experience experience is different. riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: It's based on them. It's not a and it's not what I call the big brother. You know, big big big brother is we're talking and we'll go on our Instagram in a few minutes and say there's something on there that that somehow someone's listening to my conversation. you know, it's and and we never can understand. How do they know that I was just talking about, you know, bread and that's on there, you know. so that's obviously a lot of information out there. What we're doing is we're saying based on what you are sharing, we're now gonna tailor your experience towards that. So we're not going riverside guillaume raw video cfr ingeno's studio 0080: Yeah. Ingeno: to use external things to make you feel uncomfortable. But if we know that the if we know you're talking about these areas, let's make sure that we're actually bringing those types of opportunities to you. riverside guillaume raw video cfr ingeno's studio 0080: Yeah, because they build a profile directly. They didn't structure it, but they're talking about those aspects in an unstructured way. So you kinda leverage that lake of text to to improve the profile. That's that's that's great. Brett, tell me if say another CEO, another founder, another CTO in Health Tech is listening to this and they're starting. are they they are thinking about improving their solution with AI. Not necessarily in your space exactly, but let's say in health tech in general. what would be your honest advice on where to start and what to focus on? Ingeno: the first thing I would just focus on is look at your look at your most costly processes. And should see how do I use AI to optimize those. Yeah, we we started there, it's not it's not sexy, but we started there and said that, you know, our our we're a technology company, so obviously our development is i is gonna be the most costly that we have there. But we looked at that and said what was what parts of the development ha were the most timely and costly for us? and for us it was it was very easy. It was writing requirements, writing code, and writing test cases. riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: We said, let's start there, let's get some quick wins. and once we got those quick wins, that opened up more efficiency for us. And then we started looking at are there unique values? Are are you is there something that is there something that our clients would like that is a pain point for us. And that's where we came up with the next set of actually there's interesting insights. But I would say that the riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: the the quick win is let's find some efficiencies right away. also from a CEO perspective, the great thing of a quick win is that's going to drive investor value and and every one of every one of your investors, every one of your board meetings they're gonna they're gonna hear about the AI impact and you wanna as a executive wanna be able to say, here's a true impact that we're getting out of it. So t take the quick wins and then ex expand beyond that. riverside guillaume raw video cfr ingeno's studio 0080: Yeah. All right. Brett, we're almost at time. quick lightning round of questions for you, so don't overthink it, just whatever comes to mind. what would you say is the most overrated thing in AI in health tech right now? Ingeno: Great question. I I'm trying to overthink that one. riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: so so I I would say overrated is the thought that AI is gonna take over all of electronic medical records, all of the feasibility studies, all of the assessments, and we don't need we don't need healthcare providers anymore. I think we a AI is great at finding some pointing in the right direction. But I'll tell you, very few people unless you're very few people are going to put their hands on AI to make healthcare decisions for them. You wanna talk to riverside guillaume raw video cfr ingeno's studio 0080: Yeah, yeah. Ingeno: someone who you trust. riverside guillaume raw video cfr ingeno's studio 0080: Makes sense. the one tool or system your team could not run without. Ingeno: I would say chat GPT. riverside guillaume raw video cfr ingeno's studio 0080: best engineering or product team you've ever seen and what made them stand out. Ingeno: I'm gonna be biased, with I'll be biased riverside guillaume raw video cfr ingeno's studio 0080: You can't. Ingeno: w with my with my current team. I've worked and most of my career. and I think what what is really acceptable with my current team is they think more about productivity and customer experience and less about I'm gonna impact my job. They're they're riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: they're doing things that are that are better for the company. even though it's showing that maybe we don't need as many of them or maybe we can g or maybe we can we don't need to grow. So they're riverside guillaume raw video cfr ingeno's studio 0080: Mm-hmm. Ingeno: doing things that I think are the best, but but they're they're they're accepting the technology versus using that as a hindrance. riverside guillaume raw video cfr ingeno's studio 0080: Right. Last one for you, Brett. if you were not CEO of Inspire, if you were not in software and healthcare, what would you be doing? Ingeno: well s if I could play the professional pickleball tour I would do that, but otherwise riverside guillaume raw video cfr ingeno's studio 0080: Nice. Ingeno: I'd probably would my my wife and I'd probably do something with dog rescue. Love dogs. riverside guillaume raw video cfr ingeno's studio 0080: cool. Cool. Cool. We have you have one or many? Two dogs. Nice. Ingeno: I have two dogs, I have Axel and I have Rose. So it tells you a bit a bit about my my musical taste too. riverside guillaume raw video cfr ingeno's studio 0080: Nice. Brett Klinger, this was a genuinely great conversation. Thank you so much. I really appreciate it. how specific, honest, and candid you were with your answers. so and this is exactly what this show is for. so tell me, Brett, where can our our listener follow you and see what you're building? Ingeno: so certainly the company inspire dot com. go there and I'm happy also to you know, I'm I'm a regular LinkedIn for person. That's my my social media's LinkedIn, so happy to connect with anyone and and share more insights. riverside guillaume raw video cfr ingeno's studio 0080: All right. Thanks everyone for listening to Digital Leaders Club. if you're a health tech leader like Brett with any of the challenges that we've talked today about, I'd love to continue the conversation with you. you can find us at ngeno.ca. Until next time. Thanks again, Brett. Ingeno: Thank you again. Take care. Okay, bye.